NASDAQ:NOVNNovan Stock Price, Forecast & News

Novan's stock was trading at $0.52 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, NOVN stock has decreased by 14.6% and is now trading at $0.4439. View which stocks have been most impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Novan in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Novan.

Novan is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for Novan.

Novan Inc (NASDAQ:NOVN) posted its quarterly earnings results on Wednesday, May, 20th. The company reported ($0.17) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.22) by $0.05. View Novan's earnings history.

2 analysts have issued 1-year target prices for Novan's stock. Their forecasts range from $0.50 to $1.50. On average, they expect Novan's stock price to reach $1.00 in the next year. This suggests a possible upside of 125.3% from the stock's current price. View analysts' price targets for Novan.

Headlines about NOVN stock have been trending positive on Tuesday, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Novan earned a daily sentiment score of 2.6 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutNovan.

Novan saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 1,570,000 shares, an increase of 90.1% from the April 30th total of 826,000 shares. Based on an average trading volume of 10,130,000 shares, the short-interest ratio is currently 0.2 days. Approximately 7.1% of the shares of the company are short sold. View Novan's Current Options Chain.

Some companies that are related to Novan include AVEO Pharmaceuticals (AVEO), SUMMIT THERAPEU/S (SMMT), Savara (SVRA), GlycoMimetics (GLYC), Theratechnologies (THERF), Axovant Gene Therapies (AXGT), Catabasis Pharmaceuticals (CATB), OASMIA PHARMACE/ADR (OASM), Checkpoint Therapeutics (CKPT), InflaRx (LUMO), Galmed Pharmaceuticals (GLMD), Cyclerion Therapeutics (CYCN), ESSA Pharma (EPIX), Recro Pharma (REPH) and Eton Pharmaceuticals (ETON). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Novan investors own include Amplify Energy (AMPY), Amplify Energy (AMPY), Pennsylvania R.E.I.T. (PEI), Chesapeake Energy (CHK), Matinas BioPharma (MTNB), Titan Pharmaceuticals (TTNP), ADMA Biologics (ADMA), Unum Therapeutics (UMRX), Zosano Pharma (ZSAN) and Ekso Bionics (EKSO).

(NOVN) raised $46 million in an initial public offering on Wednesday, September 21st 2016. The company issued 3,800,000 shares at a price of $11.00-$13.00 per share. Piper Jaffray acted as the underwriter for the IPO and JMP Securities and Wedbush PacGrow were co-managers.

Novan trades on the NASDAQ under the ticker symbol "NOVN."

Novan's stock is owned by a number of retail and institutional investors. Top institutional investors include Sabby Management LLC (9.70%), CIBC World Markets Inc. (2.24%) and UBS Group AG (0.11%). Company insiders that own Novan stock include G Kelly Martin, John M Gay, John W Palmour, Life Sciences Holdings L Malin, Paula B Stafford and Robert Alexander Ingram. View institutional ownership trends for Novan.

NOVN stock was purchased by a variety of institutional investors in the last quarter, including Sabby Management LLC, CIBC World Markets Inc., and UBS Group AG. Company insiders that have bought Novan stock in the last two years include G Kelly Martin, John M Gay, John W Palmour, Paula B Stafford, and Robert Alexander Ingram. View insider buying and selling activity for Novan.

Shares of NOVN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NOVN stock can currently be purchased for approximately $0.44.

Novan has a market capitalization of $33.50 million and generates $4.90 million in revenue each year. The company earns $-30,640,000.00 in net income (profit) each year or ($0.80) on an earnings per share basis. Novan employs 47 workers across the globe.

The official website for Novan is www.novan.com.

Novan's mailing address is 4105 HOPSON ROAD, MORRISVILLE NC, 27560. The company can be reached via phone at 919-485-8080 or via email at [email protected]